BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lecina M, Ting S, Choo A, Reuveny S, Oh S. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods. 2010;16:1609-1619. [PMID: 20590381 DOI: 10.1089/ten.tec.2010.0104] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Yang Z, Yuan S, Liang B, Liu Y, Choong C, Pehkonen SO. Chitosan Microsphere Scaffold Tethered with RGD-Conjugated Poly(methacrylic acid) Brushes as Effective Carriers for the Endothelial Cells: Chitosan Microsphere Scaffold Tethered with …. Macromol Biosci 2014;14:1299-311. [DOI: 10.1002/mabi.201400136] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
3 Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev 2016;96:3-17. [PMID: 25980938 DOI: 10.1016/j.addr.2015.05.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 64] [Article Influence: 14.3] [Reference Citation Analysis]
4 Chen AK, Chen X, Choo ABH, Reuveny S, Oh SKW. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Research 2011;7:97-111. [DOI: 10.1016/j.scr.2011.04.007] [Cited by in Crossref: 126] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
5 Fan Y, Hsiung M, Cheng C, Tzanakakis ES. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A 2014;20:588-99. [PMID: 24098972 DOI: 10.1089/ten.TEA.2013.0219] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
6 Low JL, Jürjens G, Seayad J, Seow J, Ting S, Laco F, Reuveny S, Oh S, Chai CL. Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells. Bioorg Med Chem Lett 2013;23:3300-3. [PMID: 23602399 DOI: 10.1016/j.bmcl.2013.03.103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
7 Loring JF, McDevitt TC, Palecek SP, Schaffer DV, Zandstra PW, Nerem RM. A global assessment of stem cell engineering. Tissue Eng Part A 2014;20:2575-89. [PMID: 24428577 DOI: 10.1089/ten.TEA.2013.0468] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
8 Serra M, Brito C, Correia C, Alves PM. Process engineering of human pluripotent stem cells for clinical application.Trends Biotechnol. 2012;30:350-359. [PMID: 22541338 DOI: 10.1016/j.tibtech.2012.03.003] [Cited by in Crossref: 217] [Cited by in F6Publishing: 182] [Article Influence: 24.1] [Reference Citation Analysis]
9 Higuchi A, Suresh Kumar S, Ling Q, Alarfaj AA, Munusamy MA, Murugan K, Hsu S, Benelli G, Umezawa A. Polymeric design of cell culture materials that guide the differentiation of human pluripotent stem cells. Progress in Polymer Science 2017;65:83-126. [DOI: 10.1016/j.progpolymsci.2016.09.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
10 Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc 2015;10:1345-61. [PMID: 26270394 DOI: 10.1038/nprot.2015.089] [Cited by in Crossref: 95] [Cited by in F6Publishing: 78] [Article Influence: 15.8] [Reference Citation Analysis]
11 Ting S, Liew SJ, Japson F, Shang F, Chong WK, Reuveny S, Tham JY, Li X, Oh S. Time‐resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays. Biotechnology Journal 2014;9:675-83. [DOI: 10.1002/biot.201300262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
12 Talkhabi M, Aghdami N, Baharvand H. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art. Life Sci. 2016;145:98-113. [PMID: 26682938 DOI: 10.1016/j.lfs.2015.12.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
13 Kempf H, Andree B, Zweigerdt R. Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv Drug Deliv Rev 2016;96:18-30. [PMID: 26658242 DOI: 10.1016/j.addr.2015.11.016] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
14 Fan Y, Zhang F, Tzanakakis ES. Engineering Xeno-Free Microcarriers with Recombinant Vitronectin, Albumin and UV Irradiation for Human Pluripotent Stem Cell Bioprocessing. ACS Biomater Sci Eng 2017;3:1510-8. [PMID: 28989958 DOI: 10.1021/acsbiomaterials.6b00253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
15 Weng Z, Kong CW, Ren L, Karakikes I, Geng L, He J, Chow MZ, Mok CF, Chan HYS, Webb SE, Keung W, Chow H, Miller AL, Leung AY, Hajjar RJ, Li RA, Chan CW. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev 2014;23:1704-16. [PMID: 24564569 DOI: 10.1089/scd.2013.0509] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 11.3] [Reference Citation Analysis]
16 Sart S, Schneider YJ, Li Y, Agathos SN. Stem cell bioprocess engineering towards cGMP production and clinical applications. Cytotechnology 2014;66:709-22. [PMID: 24500393 DOI: 10.1007/s10616-013-9687-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
17 Lam AT, Li J, Chen AK, Reuveny S, Oh SK, Birch WR. Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures. Stem Cells Dev 2014;23:1688-703. [PMID: 24641164 DOI: 10.1089/scd.2013.0645] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
18 Young PP, Schäfer R. Cell-based therapies for cardiac disease: a cellular therapist's perspective. Transfusion 2015;55:441-51; quiz 440. [PMID: 25145464 DOI: 10.1111/trf.12826] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
19 Soong PL, Tiburcy M, Zimmermann WH. Cardiac differentiation of human embryonic stem cells and their assembly into engineered heart muscle. Curr Protoc Cell Biol 2012;Chapter 23:Unit23.8. [PMID: 23129117 DOI: 10.1002/0471143030.cb2308s55] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
20 Leung HW, Moerkamp AT, Padmanabhan J, Ng SW, Goumans MJ, Choo A. mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs. J Mol Cell Cardiol 2015;82:228-37. [PMID: 25820071 DOI: 10.1016/j.yjmcc.2015.02.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Sego TJ, Prideaux M, Sterner J, McCarthy BP, Li P, Bonewald LF, Ekser B, Tovar A, Jeshua Smith L. Computational fluid dynamic analysis of bioprinted self-supporting perfused tissue models. Biotechnol Bioeng 2020;117:798-815. [PMID: 31788785 DOI: 10.1002/bit.27238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Meng G, Liu S, Poon A, Rancourt DE. Optimizing Human Induced Pluripotent Stem Cell Expansion in Stirred-Suspension Culture. Stem Cells and Development 2017;26:1804-17. [DOI: 10.1089/scd.2017.0090] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
23 Lewandowski J, Kolanowski TJ, Kurpisz M. Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes. J Tissue Eng Regen Med 2017;11:1658-74. [PMID: 26777594 DOI: 10.1002/term.2117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
24 Lam AT, Chen AK, Ting SQ, Reuveny S, Oh SK. Integrated processes for expansion and differentiation of human pluripotent stem cells in suspended microcarriers cultures. Biochem Biophys Res Commun 2016;473:764-8. [PMID: 26385176 DOI: 10.1016/j.bbrc.2015.09.079] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
25 Tohyama S, Fujita J, Fujita C, Yamaguchi M, Kanaami S, Ohno R, Sakamoto K, Kodama M, Kurokawa J, Kanazawa H, Seki T, Kishino Y, Okada M, Nakajima K, Tanosaki S, Someya S, Hirano A, Kawaguchi S, Kobayashi E, Fukuda K. Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes. Stem Cell Reports 2017;9:1406-14. [PMID: 28988990 DOI: 10.1016/j.stemcr.2017.08.025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
26 Liu N, Li Y, Yang S. Microfibrous carriers for integrated expansion and neural differentiation of embryonic stem cells in suspension bioreactor. Biochemical Engineering Journal 2013;75:55-63. [DOI: 10.1016/j.bej.2013.03.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
27 Want AJ, Nienow AW, Hewitt CJ, Coopman K. Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask. Regenerative Medicine 2012;7:71-84. [DOI: 10.2217/rme.11.101] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
28 Annab LA, Bortner CD, Sifre MI, Collins JM, Shah RR, Dixon D, Karimi Kinyamu H, Archer TK. Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines. Differentiation 2012;84:330-43. [PMID: 22906706 DOI: 10.1016/j.diff.2012.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
29 Chen AK, Chen X, Lim YM, Reuveny S, Oh SK. Inhibition of ROCK-myosin II signaling pathway enables culturing of human pluripotent stem cells on microcarriers without extracellular matrix coating. Tissue Eng Part C Methods 2014;20:227-38. [PMID: 23777438 DOI: 10.1089/ten.TEC.2013.0191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
30 Liu L, Kamei KI, Yoshioka M, Nakajima M, Li J, Fujimoto N, Terada S, Tokunaga Y, Koyama Y, Sato H, Hasegawa K, Nakatsuji N, Chen Y. Nano-on-micro fibrous extracellular matrices for scalable expansion of human ES/iPS cells. Biomaterials 2017;124:47-54. [PMID: 28187394 DOI: 10.1016/j.biomaterials.2017.01.039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
31 Ting S, Chen A, Reuveny S, Oh S. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. Stem Cell Res. 2014;13:202-213. [PMID: 25043964 DOI: 10.1016/j.scr.2014.06.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
32 Schriebl K, Satianegara G, Hwang A, Tan HL, Fong WJ, Yang HH, Jungbauer A, Choo A. Selective Removal of Undifferentiated Human Embryonic Stem Cells Using Magnetic Activated Cell Sorting Followed by a Cytotoxic Antibody. Tissue Engineering Part A 2012;18:899-909. [DOI: 10.1089/ten.tea.2011.0311] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
33 Kempf H, Lecina M, Ting S, Zweigerdt R, Oh S. Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells. Stem Cell Res. 2011;7:198-209. [PMID: 21907163 DOI: 10.1016/j.scr.2011.06.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
34 Ting S, Lecina M, Reuveny S, Oh S. Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures. Curr Protoc Stem Cell Biol. 2012;Chapter 1:Unit1D.7. [PMID: 22605644 DOI: 10.1002/9780470151808.sc01d07s21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
35 Chen A, Ting S, Seow J, Reuveny S, Oh S. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther 2014;5:12. [PMID: 24444355 DOI: 10.1186/scrt401] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
36 Badenes SM, Fernandes TG, Rodrigues CAV, Diogo MM, Cabral JMS. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. J Biotechnol 2016;234:71-82. [PMID: 27480342 DOI: 10.1016/j.jbiotec.2016.07.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
37 Chen L, Sung T, Lee HH, Higuchi A, Su H, Lin K, Huang Y, Ling Q, Kumar SS, Alarfaj AA, Munusamy MA, Nasu M, Chen D, Hsu S, Chang Y, Lee K, Wang H, Umezawa A. Xeno-free and feeder-free culture and differentiation of human embryonic stem cells on recombinant vitronectin-grafted hydrogels. Biomater Sci 2019;7:4345-62. [DOI: 10.1039/c9bm00418a] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Fridley KM, Kinney MA, McDevitt TC. Hydrodynamic modulation of pluripotent stem cells. Stem Cell Res Ther 2012;3:45. [PMID: 23168068 DOI: 10.1186/scrt136] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
39 Fonoudi H, Ansari H, Abbasalizadeh S, Larijani MR, Kiani S, Hashemizadeh S, Zarchi AS, Bosman A, Blue GM, Pahlavan S, Perry M, Orr Y, Mayorchak Y, Vandenberg J, Talkhabi M, Winlaw DS, Harvey RP, Aghdami N, Baharvand H. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells. Stem Cells Transl Med. 2015;4:1482-1494. [PMID: 26511653 DOI: 10.5966/sctm.2014-0275] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 12.8] [Reference Citation Analysis]
40 Xu C. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells. J Mol Cell Cardiol. 2012;52:1203-1212. [PMID: 22484618 DOI: 10.1016/j.yjmcc.2012.03.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
41 Sart S, Agathos SN, Li Y. Engineering stem cell fate with biochemical and biomechanical properties of microcarriers. Biotechnol Prog. 2013;29:1354-1366. [PMID: 24124017 DOI: 10.1002/btpr.1825] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
42 Rodrigues CA, Diogo MM, da Silva CL, Cabral JM. Microcarrier expansion of mouse embryonic stem cell-derived neural stem cells in stirred bioreactors. Biotechnol Appl Biochem 2011;58:231-42. [PMID: 21838797 DOI: 10.1002/bab.37] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
43 Liu N, Zang R, Yang S, Li Y. Stem cell engineering in bioreactors for large-scale bioprocessing. Eng Life Sci 2014;14:4-15. [DOI: 10.1002/elsc.201300013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 9] [Article Influence: 5.4] [Reference Citation Analysis]
44 Chan YC, Ting S, Lee YK, Ng KM, Zhang J, Chen Z, Siu CW, Oh SK, Tse HF. Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Transl Res 2013;6:989-99. [PMID: 24081385 DOI: 10.1007/s12265-013-9510-z] [Cited by in Crossref: 109] [Cited by in F6Publishing: 88] [Article Influence: 13.6] [Reference Citation Analysis]
45 Torizal FG, Horiguchi I, Sakai Y. Physiological Microenvironmental Conditions in Different Scalable Culture Systems for Pluripotent Stem Cell Expansion and Differentiation. TOBEJ 2019;13:41-54. [DOI: 10.2174/1874120701913010041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Abbasalizadeh S, Baharvand H. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol Adv. 2013;31:1600-1623. [PMID: 23962714 DOI: 10.1016/j.biotechadv.2013.08.009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
47 Ting S, Lam A, Tong G, Chen A, Wei H, Wu J, Lam YN, Reuveny S, Oh S. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess. Stem Cell Research 2018;31:161-73. [DOI: 10.1016/j.scr.2018.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
48 Yuan S, Xiong G, He F, Jiang W, Liang B, Pehkonen S, Choong C. PCL microspheres tailored with carboxylated poly(glycidyl methacrylate)–REDV conjugates as conducive microcarriers for endothelial cell expansion. J Mater Chem B 2015;3:8670-83. [DOI: 10.1039/c5tb01836f] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
49 Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch Toxicol 2011;85:79-117. [PMID: 21225242 DOI: 10.1007/s00204-010-0641-6] [Cited by in Crossref: 105] [Cited by in F6Publishing: 74] [Article Influence: 10.5] [Reference Citation Analysis]
50 Ordovás L, Park Y, Verfaillie CM. Stem cells and liver engineering. Biotechnology Advances 2013;31:1094-107. [DOI: 10.1016/j.biotechadv.2013.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
51 Anderson ME, Goldhaber J, Houser SR, Puceat M, Sussman MA. Embryonic stem cell-derived cardiac myocytes are not ready for human trials. Circ Res 2014;115:335-8. [PMID: 24935962 DOI: 10.1161/CIRCRESAHA.114.304616] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
52 Lu SJ, Kelley T, Feng Q, Chen A, Reuveny S, Lanza R, Oh SK. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected]. Regen Med. 2013;8:413-424. [PMID: 23826696 DOI: 10.2217/rme.13.36] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
53 Laco F, Lam AT, Woo TL, Tong G, Ho V, Soong PL, Grishina E, Lin KH, Reuveny S, Oh SK. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor. Stem Cell Res Ther 2020;11:118. [PMID: 32183888 DOI: 10.1186/s13287-020-01618-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
54 Fernandes TG, Diogo MM, Cabral JM. Bioreactors for stem cell culture. Stem Cell Bioprocessing. Elsevier; 2013. pp. 69-114. [DOI: 10.1533/9781908818300.69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
55 Lam AT, Chen AK, Li J, Birch WR, Reuveny S, Oh SK. Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture. Stem Cell Res Ther 2014;5:110. [PMID: 25223792 DOI: 10.1186/scrt498] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
56 Chen AK, Reuveny S, Oh SKW. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction. Biotechnology Advances 2013;31:1032-46. [DOI: 10.1016/j.biotechadv.2013.03.006] [Cited by in Crossref: 179] [Cited by in F6Publishing: 149] [Article Influence: 22.4] [Reference Citation Analysis]
57 Le MNT, Hasegawa K. Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes. Bioengineering (Basel) 2019;6:E48. [PMID: 31137703 DOI: 10.3390/bioengineering6020048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
58 Kashani IR, Zarnani AH, Soleimani M, Abdolvahabi MA, Nayernia K, Shirazi R. Retinoic acid induces mouse bone marrow-derived CD15⁺, Oct4⁺ and CXCR4⁺ stem cells into male germ-like cells in a two-dimensional cell culture system. Cell Biol Int 2014;38:782-9. [PMID: 24677291 DOI: 10.1002/cbin.10260] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Bardy J, Chen AK, Lim YM, Wu S, Wei S, Weiping H, Chan K, Reuveny S, Oh SK. Microcarrier Suspension Cultures for High-Density Expansion and Differentiation of Human Pluripotent Stem Cells to Neural Progenitor Cells. Tissue Engineering Part C: Methods 2013;19:166-80. [DOI: 10.1089/ten.tec.2012.0146] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 10.0] [Reference Citation Analysis]
60 Sung TC, Su HC, Ling QD, Kumar SS, Chang Y, Hsu ST, Higuchi A. Efficient differentiation of human pluripotent stem cells into cardiomyocytes on cell sorting thermoresponsive surface. Biomaterials 2020;253:120060. [PMID: 32450407 DOI: 10.1016/j.biomaterials.2020.120060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
61 Ashton RS, Keung AJ, Peltier J, Schaffer DV. Progress and prospects for stem cell engineering. Annu Rev Chem Biomol Eng 2011;2:479-502. [PMID: 22432628 DOI: 10.1146/annurev-chembioeng-061010-114105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
62 Park Y, Chen Y, Ordovas L, Verfaillie CM. Hepatic differentiation of human embryonic stem cells on microcarriers. J Biotechnol. 2014;174:39-48. [PMID: 24480567 DOI: 10.1016/j.jbiotec.2014.01.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
63 Higuchi A, Ling Q, Kumar SS, Chang Y, Alarfaj AA, Munusamy MA, Murugan K, Hsu S, Umezawa A. Physical cues of cell culture materials lead the direction of differentiation lineages of pluripotent stem cells. J Mater Chem B 2015;3:8032-58. [DOI: 10.1039/c5tb01276g] [Cited by in Crossref: 51] [Article Influence: 8.5] [Reference Citation Analysis]
64 Fernandes TG, Rodrigues CA, Diogo MM, Cabral JM. Stem cell bioprocessing for regenerative medicine: Stem cell bioprocessing. J Chem Technol Biotechnol 2014;89:34-47. [DOI: 10.1002/jctb.4189] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
65 Rodrigues CA, Fernandes TG, Diogo MM, da Silva CL, Cabral JM. Stem cell cultivation in bioreactors. Biotechnol Adv. 2011;29:815-829. [PMID: 21726624 DOI: 10.1016/j.biotechadv.2011.06.009] [Cited by in Crossref: 144] [Cited by in F6Publishing: 110] [Article Influence: 14.4] [Reference Citation Analysis]
66 Lam AT, Li J, Chen AK, Birch WR, Reuveny S, Oh SK. Improved Human Pluripotent Stem Cell Attachment and Spreading on Xeno-Free Laminin-521-Coated Microcarriers Results in Efficient Growth in Agitated Cultures. Biores Open Access 2015;4:242-57. [PMID: 26309800 DOI: 10.1089/biores.2015.0010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
67 Heng BC, Li J, Chen AK, Reuveny S, Cool SM, Birch WR, Oh SK. Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev. 2012;21:1701-1715. [PMID: 22034857 DOI: 10.1089/scd.2011.0509] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
68 Lembong J, Kirian R, Takacs JD, Olsen TR, Lock LT, Rowley JA, Ahsan T. Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel System. Bioengineering (Basel) 2020;7:E73. [PMID: 32650422 DOI: 10.3390/bioengineering7030073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
69 Lundy SD, Gantz JA, Pagan CM, Filice D, Laflamme MA. Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr Treat Options Cardiovasc Med. 2014;16:319. [PMID: 24838687 DOI: 10.1007/s11936-014-0319-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
70 Blazeski A, Zhu R, Hunter DW, Weinberg SH, Boheler KR, Zambidis ET, Tung L. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol. 2012;110:178-195. [PMID: 22958937 DOI: 10.1016/j.pbiomolbio.2012.07.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
71 Mirfeizi L, Stratton JA, Kumar R, Shah P, Agabalyan N, Stykel MG, Midha R, Biernaskie J, Kallos MS. Serum-free bioprocessing of adult human and rodent skin-derived Schwann cells: implications for cell therapy in nervous system injury. J Tissue Eng Regen Med 2017;11:3385-97. [PMID: 28176458 DOI: 10.1002/term.2252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
72 García-fernández C, López-fernández A, Borrós S, Lecina M, Vives J. Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells. Biochemical Engineering Journal 2020;159:107601. [DOI: 10.1016/j.bej.2020.107601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
73 Higuchi A, Ling Q, Chang Y, Hsu S, Umezawa A. Physical Cues of Biomaterials Guide Stem Cell Differentiation Fate. Chem Rev 2013;113:3297-328. [DOI: 10.1021/cr300426x] [Cited by in Crossref: 295] [Cited by in F6Publishing: 243] [Article Influence: 36.9] [Reference Citation Analysis]
74 Jenkins MJ, Farid SS. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J 2015;10:83-95. [PMID: 25524780 DOI: 10.1002/biot.201400348] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
75 Caldwell AS, Aguado BA, Anseth KS. Designing Microgels for Cell Culture and Controlled Assembly of Tissue Microenvironments. Adv Funct Mater 2020;30:1907670. [PMID: 33841061 DOI: 10.1002/adfm.201907670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
76 Amit M, Laevsky I, Miropolsky Y, Shariki K, Peri M, Itskovitz-Eldor J. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat Protoc 2011;6:572-9. [PMID: 21527915 DOI: 10.1038/nprot.2011.325] [Cited by in Crossref: 118] [Cited by in F6Publishing: 90] [Article Influence: 11.8] [Reference Citation Analysis]
77 Magdy T, Schuldt AJT, Wu JC, Bernstein D, Burridge PW. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems. Annu Rev Pharmacol Toxicol. 2018;58:83-103. [PMID: 28992430 DOI: 10.1146/annurev-pharmtox-010617-053110] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
78 Chen KG, Mallon BS, McKay RD, Robey PG. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell. 2014;14:13-26. [PMID: 24388173 DOI: 10.1016/j.stem.2013.12.005] [Cited by in Crossref: 213] [Cited by in F6Publishing: 173] [Article Influence: 30.4] [Reference Citation Analysis]
79 Coopman K. Large-scale compatible methods for the preservation of human embryonic stem cells: Current perspectives. Biotechnol Progress 2011;27:1511-21. [DOI: 10.1002/btpr.680] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]